SPOTLIGHT -
The Neurochemistry of Pediatric Major Depressive Disorder
Major depressive disorder (MDD) in pediatric populations represents a significant public health concern. Rates of MDD rise dramatically in adolescence, with an estimated lifetime prevalence of 15% in adolescents aged 15 to 18.
